Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years
- PMID: 30761683
- PMCID: PMC6538270
- DOI: 10.1002/pon.5028
Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years
Abstract
Objective: Fatigue and cognitive dysfunction are major concerns for women with early-stage breast cancer during treatment and into survivorship. However, interrelationships of these phenomena and their temporal patterns over time are not well documented, thus limiting the strategies for symptom management interventions. In this study, changes in fatigue across treatment phases and the relationship among fatigue severity and its functional impact with objective cognitive performance were examined.
Methods: Participants (N = 75) were assessed at five time points beginning prior to chemotherapy to 24 months after initial chemotherapy. Fatigue severity and impact were measured on the Brief Fatigue Inventory. Central nervous system (CNS) Vital Signs was used to measure performance based cognitive testing. Temporal changes in fatigue were examined, as well as the relationship between fatigue and cognitive performance, at each time point using linear mixed effect models.
Results: Severity of fatigue varied as a function of phase of treatment. Fatigue severity and its functional impact were moderate at baseline, increased significantly during chemotherapy, and returned to near baseline levels by 2 years. At each time point, fatigue severity and impact were significantly associated with diminished processing speed and complex attention performance.
Conclusions: A strong association between fatigue and objective cognitive performance suggests that they are likely functionally related. That cognitive deficits were evident at baseline, whereas fatigue was more chemotherapy dependent, implicates that two symptoms share some common bases but may differ in underlying mechanisms and severity over time. This knowledge provides a basis for introducing strategies for tailored symptom management that vary over time.
Keywords: breast cancer; cancer; chemobrain; chemotherapy; cognition; fatigue; longitudinal; oncology.
© 2019 John Wiley & Sons, Ltd.
Conflict of interest statement
Conflict of Interest Statement: Authors Gullett, Cohen, Yang, Menzies, Fieo, Kelly, Starkweather, Jackson-Cook, and Lyon declare that they have no conflict of interest.
Figures
Similar articles
-
Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.Psychooncology. 2018 Mar;27(3):802-809. doi: 10.1002/pon.4571. Epub 2017 Nov 21. Psychooncology. 2018. PMID: 29055062 Free PMC article.
-
Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.Support Care Cancer. 2018 Feb;26(2):575-583. doi: 10.1007/s00520-017-3869-3. Epub 2017 Aug 28. Support Care Cancer. 2018. PMID: 28849337 Free PMC article.
-
The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.J Cancer Res Clin Oncol. 2016 Jul;142(7):1461-74. doi: 10.1007/s00432-016-2163-y. Epub 2016 Apr 21. J Cancer Res Clin Oncol. 2016. PMID: 27102492 Free PMC article.
-
Neuropsychological Effects of Chemotherapy: Systematic Review of Longitudinal Studies on Objective Cognitive Impairment in Breast Cancer Patients.Cancer Nurs. 2023 May-Jun 01;46(3):E159-E168. doi: 10.1097/NCC.0000000000001079. Epub 2022 Mar 24. Cancer Nurs. 2023. PMID: 35324504
-
Biobehavioral Mechanisms Associated With Nonhealing Wounds and Psychoneurologic Symptoms (Pain, Cognitive Dysfunction, Fatigue, Depression, and Anxiety) in Older Individuals With Chronic Venous Leg Ulcers.Biol Res Nurs. 2019 Jul;21(4):407-419. doi: 10.1177/1099800419853881. Epub 2019 May 29. Biol Res Nurs. 2019. PMID: 31142148 Free PMC article. Review.
Cited by
-
Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer.Cancer Med. 2021 Feb;10(4):1191-1200. doi: 10.1002/cam4.3715. Epub 2021 Jan 16. Cancer Med. 2021. PMID: 33455070 Free PMC article.
-
Changes in Attentional Function in Patients From Before Through 12 Months After Breast Cancer Surgery.J Pain Symptom Manage. 2020 Jun;59(6):1172-1185. doi: 10.1016/j.jpainsymman.2020.01.001. Epub 2020 Jan 15. J Pain Symptom Manage. 2020. PMID: 31953207 Free PMC article.
-
Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.Cancer. 2020 Mar 15;126(6):1183-1192. doi: 10.1002/cncr.32663. Epub 2019 Dec 20. Cancer. 2020. PMID: 31860135 Free PMC article.
-
Genetic variability of oxidative stress and DNA repair genes associated with pre-treatment cancer-related fatigue in women with breast cancer.Support Care Cancer. 2023 May 22;31(6):345. doi: 10.1007/s00520-023-07816-1. Support Care Cancer. 2023. PMID: 37212918
-
Perceived Executive Functioning Deficits After Diagnosis in Women with Non-Metastatic Breast Cancer Prior to Adjuvant Therapies.Int J Behav Med. 2024 Feb;31(1):31-40. doi: 10.1007/s12529-023-10153-6. Epub 2023 Jan 31. Int J Behav Med. 2024. PMID: 36720774
References
-
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2016;66(4):271–289. - PubMed
-
- Sanford SD, Beaumont JL, Butt Z, Sweet JJ, Cella D, Wagner LI. Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage. 2014;47(4):721–730. - PubMed
-
- Abrahams HJ, Gielissen MF, Schmits IC, Verhagen CA, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016;27(6):965–974. - PubMed
-
- Reinertsen KV, Engebraaten O, Loge JH, et al. Fatigue during and after breast cancer therapy-a prospective study. J Pain Symptom Manage. 2017;53(3):551–560. - PubMed
-
- Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv. 2018;12(4):537–559. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical